June 22, 2026 · Blood · DOI: 10.1182/blood.2025030831

Niche-targeted therapy via YAP/TAZ activation enhances hematopoietic regeneration

Listen to this summary

The authors investigate the role of YAP/TAZ activation in enhancing hematopoietic regeneration following myeloablative stress, focusing on how these pathways can restore the bone marrow niche that supports hematopoietic stem cells (HSCs). They demonstrate that YAP/TAZ are crucial for the recovery of endothelial cells and mesenchymal stromal cells, which in turn promotes efficient hematopoietic recovery. The study suggests that pharmacological activation of YAP/TAZ could serve as a therapeutic strategy to improve hematopoietic regeneration by enhancing niche resilience.

Shun Uemura, Masayuki Yamashita, Takako Yokomizo-Nakano, Ayako Aihara, Takumi Iwawaki, Shuhei Koide, Yaeko Nakajima-Takagi, Motohiko Oshima, Yoshiki Omatsu, Yuki Matsumoto, Yoshiaki Kubota, Bahityar Rahmutulla, Atsushi Kaneda, Miki Nishio, Akira Suzuki, Takashi Nagasawa, Kenta Kagaya, Taito Nishino, Atsushi Iwama

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play